SCHEMBL6136348

SCHEMBL6136348

CC(C(=O)O)c1ccc(NC(=O)Nc2ccccc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.63
SENP7 Q9BQF6 1/20 0.63
SMN1; SMN2 Q16637 2/20 0.61
EPHX1 P07099 2/20 0.61
TP53 P04637 1/20 0.61
TSHR P16473 1/20 0.61
EPHX2 P34913 1/20 0.61
CDK9 P50750 1/20 0.61
CLK4 Q9HAZ1 1/20 0.61
TAAR1 Q96RJ0 3/20 0.59
NPC1 O15118 3/20 0.59
RAB9A P51151 3/20 0.59
KMT2A Q03164 3/20 0.59
PTGS2 P35354 1/20 0.59
HSD17B10 Q99714 1/20 0.57
MAOA P21397 2/20 0.56
MAOB P27338 2/20 0.56
MAPT P10636 3/20 0.56
NR1H4 Q96RI1 1/20 0.55
MEN1 O00255 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9425109 0.87 PTGS2 (0.66) CASP3SENP7SMN1; SMN2TSHRKMT2A
SCHEMBL4117858 0.85 RAB9A (0.67) CASP3SENP7SMN1; SMN2EPHX1TP53
SCHEMBL7479983 0.83 NR1H4 (0.59) SMN1; SMN2TSHRKMT2APTGS2MAPT
SCHEMBL297860 0.83 NR1H4 (0.73) SMN1; SMN2NPC1RAB9AKMT2APTGS2
SCHEMBL8579300 0.83 NR1H4 (0.73) SMN1; SMN2NPC1RAB9AKMT2APTGS2
SCHEMBL29142718 0.82 SMN1; SMN2 (0.61) CASP3SENP7SMN1; SMN2EPHX1TP53
SCHEMBL9823526 0.81 POLB (0.58) SMN1; SMN2TSHRTAAR1NPC1RAB9A
Diphenylamine SCHEMBL2784540 0.81 PTGS2 (0.62) CASP3SENP7SMN1; SMN2TSHRKMT2A
SCHEMBL11059378 0.80 SMN1; SMN2 (0.94) CASP3SENP7SMN1; SMN2EPHX1TP53
SCHEMBL2172516 0.80 KIF11 (0.64) TSHRNPC1KMT2APTGS2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042279-B1 SUBSTITUTED BETA-ALANINES AVENTIS PHARMA LTD (GB) 2005-03-02 EP disclosed
US-6352977-B1 ALANINE WITH PRODRUGS AVENTIS PHARMA LIMITED (GB) 2002-03-05 US disclosed
EP-1042279-A1 SUBSTITUTED BETA-ALANINES Aventis Pharma Limited (GB) 2000-10-11 EP disclosed
WO-1999033789-A1 SUBSTITUTED β-ALANINES AVENTIS PHARMA LIMITED (GB) 1999-07-08 WO disclosed